If approved, Proposition 14 would authorize the state to sell $5.5 billion in bonds to extend the life of CIRM, which funds stem cell research. The ballot measure has its critics.

The highest court in the country has declined to hear an appeal regarding the federal funding of human embryonic stem cell research, allowing such spending to continue.

A US Appeal court rules that the National Institutes of Health is legally allowed to fund human embryonic stem cell research.

A judicial technicality may decide the fate of NIH-funded human embryonic stem cell research.

Some are worried that the judges scheduled to hear arguments on the legality of federal support for human embryonic stem cell research will rule against stem cell funding.

Following last week’s ruling by the European Court of Justice that research procedures involving human embryonic stem cells cannot be patented, European researchers, lawyers, and investors are striving to put a positive spin on the decision.